Ask Warren

JONBUR Research · Initiation

You're reading an earlier report from Oct 18, 2026. See the latest report

LivsMed · 491000 · Medical & precision devices

LivsMed: Loss-Making Medical Device Maker Trades at 6.7x Book After Sharp One-Month Rally

Why this report

Start of coverage: one of the 300 largest companies, written once its financial statements were in.

LivsMed, a KOSDAQ-listed medical device company that listed in December 2025, closed at ₩43,600 on 2026-10-16, up 59.4% over one month but well below its 52-week high of ₩95,900. The filings show revenue of ₩51.2B with an operating loss of ₩22.6B, and the valuation model has no estimate.

Written Oct 18, 2026 · Data as of Oct 16, 2026 · 0 views

This is not financial advice. The report does not recommend buying or selling anything.

XfWATGr/in@

Thesis

The data supports a picture of an early-stage, loss-making company with a strong balance sheet and a high market valuation. Market capitalisation is ₩1.10T against revenue of ₩51.2B, a price-to-sales ratio of 21.5. The shares have risen 59.4% in one month and 15.2% in three months, but remain 54.5% below the 52-week high of ₩95,900 and 60.9% above the low of ₩27,100.

What the data does not show: there is no earnings-based multiple because the company is loss-making, no valuation model estimate, no short-balance figure, no one-year return (the stock has listed for under a year) and no recent news headlines. Investor flows over 20 days show retail buying of ₩22.3B against foreign selling of ₩16.1B and institutional selling of ₩6.1B. Foreign ownership fell from 4.5% to 3.2% over 60 days.

Business overview

LivsMed is listed on KOSDAQ in the medical and precision devices sector. It was founded on 2011-06-16 and listed on 2025-12-24, with 25,255,271 shares outstanding. The CEO is listed as 이정주. The data gives no description of products or customers, so this report does not comment on them. Filings show it decided to acquire tangible assets (a major matters report, amended on 2026-06-22), a stock option exercise on 2026-07-03, and several insider shareholding reports and a 5%+ holding report on 2026-07-10.

Every earlier JONBUR Research report and update note on LivsMed, with Pro.

Unlock with Pro

Model estimate of fair value

The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).

Filings and data used

Report history

  1. Oct 19, 2026Update noteBig price moveLivsMed Shares Rise 27.2% in Five Sessions on Heavier Volume
  2. Oct 18, 2026InitiationStart of coverage (300 largest)LivsMed: Loss-Making Medical Device Maker Trades at 6.7x Book After Sharp One-Month Rally

Built only from jonbur's own data: prices and investor flows, filed financial statements and filings, and news headlines. Disclosed (filed) data is labelled as such. Written by AI and may contain mistakes.

This is not financial advice. The report does not recommend buying or selling anything.

Source: KRX statistical information